| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.M310206200 |
| P698 | PubMed publication ID | 14576152 |
| P50 | author | William J. Ray | Q55763041 |
| P2093 | author name string | Jian Xu | |
| Leonard P Freedman | |||
| Donald B Kimmel | |||
| Michael A Gentile | |||
| Pascale V Nantermet | |||
| Paul Hodor | |||
| Sharon Adamski | |||
| Shun-Ichi Harada | |||
| Daniel Holder | |||
| David Gerhold | |||
| Yuanjiang Yu | |||
| P2860 | cites work | P-CIP1, a novel protein that interacts with the cytosolic domain of peptidylglycine alpha-amidating monooxygenase, is associated with endosomes | Q22008506 |
| Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1 | Q22008661 | ||
| Compromised HOXA5 function can limit p53 expression in human breast tumours | Q22254441 | ||
| Cardiac malformations, adrenal agenesis, neural crest defects and exencephaly in mice lacking Cited2, a new Tfap2 co-activator | Q24291867 | ||
| Glucose catabolism in cancer cells. The type II hexokinase promoter contains functionally active response elements for the tumor suppressor p53 | Q24308421 | ||
| Control of cell cycle exit and entry by protein kinase B-regulated forkhead transcription factors | Q24537205 | ||
| Targeted deletion of Minpp1 provides new insight into the activity of multiple inositol polyphosphate phosphatase in vivo | Q24551809 | ||
| The promoter of the prostate-specific antigen gene contains a functional androgen responsive element | Q41655072 | ||
| Oxytocin: a paracrine regulator of prostatic function | Q41670905 | ||
| Age-dependency and regional distribution of enkephalinergic nerves in human prostate | Q41982149 | ||
| Where Notch and Wnt signaling meet. The presenilin hub | Q42275044 | ||
| Androgen-driven prostate epithelial cell proliferation and differentiation in vivo involve the regulation of p27. | Q42503602 | ||
| Cell proliferation studies in the rat prostate: II. The effects of castration and androgen-induced regeneration upon basal and secretory cell proliferation | Q42524367 | ||
| Importance of vascular phenotype by basic fibroblast growth factor, and influence of the angiogenic factors basic fibroblast growth factor/fibroblast growth factor receptor-1 and ephrin-A1/EphA2 on melanoma progression | Q42794629 | ||
| Ca2+ pools and cell growth. Evidence for sarcoendoplasmic Ca2+-ATPases 2B involvement in human prostate cancer cell growth control | Q43770504 | ||
| In vitro evidence for complex modes of nuclear beta-catenin signaling during prostate growth and tumorigenesis | Q43966868 | ||
| Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo. | Q44172489 | ||
| Gene expression profiling of androgen deficiency predicts a pathway of prostate apoptosis that involves genes related to oxidative stress. | Q44226051 | ||
| A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens | Q44507804 | ||
| Kalirin, a cytosolic protein with spectrin-like and GDP/GTP exchange factor-like domains that interacts with peptidylglycine alpha-amidating monooxygenase, an integral membrane peptide-processing enzyme | Q48049856 | ||
| p53 represses androgen-induced transactivation of prostate-specific antigen by disrupting hAR amino- to carboxyl-terminal interaction. | Q52543669 | ||
| Abnormal expression of MDM2 in prostate carcinoma. | Q53398985 | ||
| Somatic Mutation and Germline Variants of MINPP1, a Phosphatase Gene Located in Proximity to PTEN on 10q23.3, in Follicular Thyroid Carcinomas | Q56593914 | ||
| Evidence that Golgi structure depends on a p115 activity that is independent of the vesicle tether components giantin and GM130 | Q24653564 | ||
| Dorsal horn-enriched genes identified by DNA microarray, in situ hybridization and immunohistochemistry | Q24803220 | ||
| Expression monitoring by hybridization to high-density oligonucleotide arrays | Q27860473 | ||
| PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer | Q27860985 | ||
| Id proteins in cell cycle control and cellular senescence | Q28200729 | ||
| Characterization of the Epha1 receptor tyrosine kinase: expression in epithelial tissues | Q28214281 | ||
| Linking beta-catenin to androgen-signaling pathway | Q28215632 | ||
| Identification of genes associated with stromal hyperplasia and glandular atrophy of the prostate by mRNA differential display | Q28289739 | ||
| Induction of the growth inhibitor IGF-binding protein 3 by p53 | Q28289896 | ||
| Loss of presenilin 1 is associated with enhanced beta-catenin signaling and skin tumorigenesis | Q28594871 | ||
| Delineation of prognostic biomarkers in prostate cancer | Q29617971 | ||
| Androgen receptor phosphorylation. Regulation and identification of the phosphorylation sites | Q30309352 | ||
| Id-1, ITF-2, and Id-2 comprise a network of helix-loop-helix proteins that regulate mammary epithelial cell proliferation, differentiation, and apoptosis | Q30706487 | ||
| Cloning and characterization of Sel-1l, a murine homolog of the C. elegans sel-1 gene | Q31951126 | ||
| Transforming growth factor-beta in benign and malignant prostate | Q33645241 | ||
| Regulation of p53 stability | Q33807793 | ||
| Neuroendocrine cells in tumour growth of the prostate | Q33871591 | ||
| Prostasomes: current concepts | Q33910602 | ||
| Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression | Q33944717 | ||
| Molecular biology of the androgen receptor | Q33959917 | ||
| Differential modulation of androgen receptor-mediated transactivation by Smad3 and tumor suppressor Smad4. | Q33961300 | ||
| Molecular genetics of prostate cancer. | Q34052664 | ||
| Peptide amidation | Q34122809 | ||
| p53-Mdm2--the affair that never ends | Q34605732 | ||
| Testosterone and prolactin regulation of metabolic genes and citrate metabolism of prostate epithelial cells | Q34799969 | ||
| Hormonal, cellular, and molecular control of prostatic development | Q35088639 | ||
| Deregulated expression of insulin-like growth factor 1 in prostate epithelium leads to neoplasia in transgenic mice | Q35112453 | ||
| Functional characterization of an androgen response element in the first intron of the C3(1) gene of prostatic binding protein | Q36276651 | ||
| Physiology of the prostate | Q37765835 | ||
| Identification and characterization of two androgen response regions in the human neutral endopeptidase gene | Q38304514 | ||
| Reduction of wild type p53 function confers a hormone resistant phenotype on LNCaP prostate cancer cells | Q40782159 | ||
| Different expression of androgen receptor coactivators in human prostate | Q40787955 | ||
| Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway | Q40808897 | ||
| Regulation of prostatic growth and function by peptide growth factors | Q40998070 | ||
| Androgens and the control of lipid metabolism in human prostate cancer cells. | Q41017473 | ||
| Opioid alkaloids and casomorphin peptides decrease the proliferation of prostatic cancer cell lines (LNCaP, PC3 and DU145) through a partial interaction with opioid receptors | Q41079050 | ||
| Early growth response-1-dependent apoptosis is mediated by p53. | Q41094563 | ||
| The Notch pathway: democracy and aristocracy in the selection of cell fate | Q41235476 | ||
| Androgenic and antiandrogenic control on epidermal growth factor, epidermal growth factor receptor, and androgen receptor expression in human prostate cancer cell line LNCaP. | Q41337540 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1310-1322 | |
| P577 | publication date | 2003-10-23 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Identification of genetic pathways activated by the androgen receptor during the induction of proliferation in the ventral prostate gland | |
| P478 | volume | 279 |
| Q40091387 | A regulatory circuit mediating convergence between Nurr1 transcriptional regulation and Wnt signaling |
| Q37664867 | APRIN is a unique Pds5 paralog with features of a chromatin regulator in hormonal differentiation |
| Q82944004 | Alanine aminotransferase regulation by androgens in non-hepatic tissues |
| Q42290415 | Amino-terminal enhancer of split gene AES encodes a tumor and metastasis suppressor of prostate cancer |
| Q40399537 | Androgen regulates apoptosis induced by TNFR family ligands via multiple signaling pathways in LNCaP. |
| Q28486024 | Androgen signaling promotes translation of TMEFF2 in prostate cancer cells via phosphorylation of the α subunit of the translation initiation factor 2 |
| Q39583449 | Androgens modulate autophagy and cell death via regulation of the endoplasmic reticulum chaperone glucose-regulated protein 78/BiP in prostate cancer cells |
| Q37395769 | Anti-acne agents attenuate FGFR2 signal transduction in acne |
| Q37389921 | Antisense MDM2 enhances E2F1-induced apoptosis and the combination sensitizes androgen-sensitive [corrected] and androgen-insensitive [corrected] prostate cancer cells to radiation |
| Q37564733 | Caveolin-1 regulates hormone resistance through lipid synthesis, creating novel therapeutic opportunities for castration-resistant prostate cancer |
| Q24685498 | Chemistry and structural biology of androgen receptor |
| Q53001344 | Chromosome damage, apoptosis, and necrosis in exfoliated cells of oral mucosa from androgenic anabolic steroids users. |
| Q36817627 | Decreased tumorigenesis and mortality from bladder cancer in mice lacking urothelial androgen receptor. |
| Q38437210 | Direct cancer tissue proteomics: a method to identify candidate cancer biomarkers from formalin-fixed paraffin-embedded archival tissues |
| Q33883203 | Discovery of the selective androgen receptor modulator MK-0773 using a rational development strategy based on differential transcriptional requirements for androgenic anabolism versus reproductive physiology |
| Q43755336 | Effect of surgical castration on expression of TRPM8 in urogenital tract of male rats |
| Q35222591 | Enhanced hematopoietic stem cell function mediates immune regeneration following sex steroid blockade |
| Q35317705 | Estrogenic environmental chemicals and drugs: mechanisms for effects on the developing male urogenital system |
| Q39853440 | Expression, regulation and function of the ISGylation system in prostate cancer |
| Q40156040 | Gum mastic increases maspin expression in prostate cancer cells |
| Q33823680 | Hey1, a mediator of notch signaling, is an androgen receptor corepressor |
| Q39018262 | Identification of Hsf1 as a novel androgen receptor-regulated gene in mouse Sertoli cells |
| Q35008907 | Identification of anabolic selective androgen receptor modulators with reduced activities in reproductive tissues and sebaceous glands |
| Q40271676 | Identification of genes targeted by the androgen and PKA signaling pathways in prostate cancer cells |
| Q50420907 | Impact of Phosphoproteomics in the Era of Precision Medicine for Prostate Cancer |
| Q36049081 | In silico analysis identifies a novel role for androgens in the regulation of human endometrial apoptosis. |
| Q36811138 | Ion channels in death and differentiation of prostate cancer cells. |
| Q35558873 | Isotretinoin and FoxO1: A scientific hypothesis |
| Q33438492 | Lef1 haploinsufficient mice display a low turnover and low bone mass phenotype in a gender- and age-specific manner |
| Q46484336 | Nandrolone decanoate modulates cell cycle regulation in functionally overloaded rat soleus muscle |
| Q41464948 | Notch and TGFβ form a reciprocal positive regulatory loop that suppresses murine prostate basal stem/progenitor cell activity |
| Q38367417 | Notch signaling in the prostate: critical roles during development and in the hallmarks of prostate cancer biology |
| Q34982347 | Notch signaling proteins: legitimate targets for cancer therapy |
| Q39818559 | Novel flufenamic acid analogues as inhibitors of androgen receptor mediated transcription |
| Q25257815 | Nuclear receptor regulation gears up another Notch |
| Q34545497 | Orai1 contributes to the establishment of an apoptosis-resistant phenotype in prostate cancer cells. |
| Q37163442 | Periocular sebaceous gland carcinoma: A comprehensive review. |
| Q35841873 | Physiological and pathological consequences of the interactions of the p53 tumor suppressor with the glucocorticoid, androgen, and estrogen receptors. |
| Q37619869 | Prostate cancer and the unfolded protein response. |
| Q24293343 | Protein phosphatase 6 subunit with conserved Sit4-associated protein domain targets IkappaBepsilon |
| Q38606010 | Recent Developments in Androgen Receptor Antagonists |
| Q39363633 | Regulation of a novel androgen receptor target gene, the cyclin B1 gene, through androgen-dependent E2F family member switching |
| Q46137928 | Regulation of apical blebbing in the porcine epididymis. |
| Q33716980 | Role of FGFR2-signaling in the pathogenesis of acne |
| Q53085316 | The CAG repeat polymorphism of androgen receptor gene and prostate cancer: a meta-analysis. |
| Q38336407 | The calcium sensor STIM1 is regulated by androgens in prostate stromal cells |
| Q34754727 | The role of RXFP2 in mediating androgen-induced inguinoscrotal testis descent in LH receptor knockout mice |
| Q39945610 | Tissue prostate-specific antigen facilitates refractory prostate tumor progression via enhancing ARA70-regulated androgen receptor transactivation |
| Q36697482 | Tissue-selective regulation of androgen-responsive genes |
| Q33699091 | Transcription factors involved in prostate gland adaptation to androgen deprivation |
| Q33301957 | Transcriptional profiling of inductive mesenchyme to identify molecules involved in prostate development and disease |
| Q30464673 | Transcriptomic analysis of the developing and adult mouse cochlear sensory epithelia. |
| Q37187309 | c-MYC-induced sebaceous gland differentiation is controlled by an androgen receptor/p53 axis |
Search more.